CD133 Antigen as a Potential Marker of Melanoma Stem Cells: In Vitro and In Vivo Studies

Figure 5

Tumor characteristic after end of follow-up: (a) average mass of tumors depending on the phenotype and number of implanted cells; (b) average values of necrosis areas in tumors depending on the phenotype and number of implanted cells; (c) average values of mitotic counts in tumors depending on the phenotype and number of implanted cells; (100+)— B16-F10 cells expressing CD133 antigen implanted to mice; (100-)— B16-F10 cells without expression of CD133 antigen implanted to mice.

(a)

(b)

(c)